Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients… https://t.co/68QuQj2ik5
    about 9 hours ago
  • New post on Science and Enterprise: FDA Clears Stem Cell Trial for Multiple Sclerosis https://t.co/iLohWcDKEC #Science #Business
    about 9 hours ago
  • A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer's… https://t.co/YBoAZKBjBw
    about 1 day ago
  • New post on Science and Enterprise: Alzheimer’s Digital Biomarkers Project Gains New Funds https://t.co/lxhfwd4Bzi #Science #Business
    about 1 day ago
  • Shionogi starts clinical test on oral COVID drug | NHK WORLD-JAPAN News https://t.co/EAQvk9nGjw
    about 2 days ago

Please share Science & Enterprise

Patent Awarded for Safer Cancer Drug Delivery

Chemotherapy vials

A pharmaceutical R&D company is receiving a patent for its process that encapsulates and better targets chemotherapy drugs for cancer patients. . . . → Read More: Patent Awarded for Safer Cancer Drug Delivery

Flexible Electrodes Devised for Implanted Devices

Hydrogel electrode

Biomedical engineers designed flexible electrodes that in lab tests safely connect and deliver electrical current to animal hearts and brains. . . . → Read More: Flexible Electrodes Devised for Implanted Devices

Plant-Based Lipids Developed for mRNA Vaccines

Vesicles

Chemists at industry and academic labs created safer lipids for delivering messenger RNA vaccines, such as those protecting against Covid-19. . . . → Read More: Plant-Based Lipids Developed for mRNA Vaccines

Start-Up Designing Synthetic DNA for Gene Therapies

DNA puzzle

A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses. . . . → Read More: Start-Up Designing Synthetic DNA for Gene Therapies

Novavax Joins Alternative Second Shot Vaccine Trial

Syringes

Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations. . . . → Read More: Novavax Joins Alternative Second Shot Vaccine Trial

Infectious Disease Biotech Raises $100M in Venture Funds

Syringe and three vials

A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds

In-Body Gene Editing Tested as Sickle Cell Treatment

Crispr graphic

Tests with lab mice show the feasibility of editing genes in blood-forming stem cells in bone marrow as a potential treatment for sickle cell disease. . . . → Read More: In-Body Gene Editing Tested as Sickle Cell Treatment

Sensor in Works Detecting Covid-19 Airborne Virus

Graphene illustration

A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV-2 viruses in indoor air. . . . → Read More: Sensor in Works Detecting Covid-19 Airborne Virus

Novavax, J&J Return Mixed Covid-19 Vaccine Results

Syringe and three vials

Results from international clinical trials show largely favorable results for two Covid-19 vaccines, but still limitations against the South African variant. . . . → Read More: Novavax, J&J Return Mixed Covid-19 Vaccine Results

Simpler Method Devised to Validate Covid-19 Tests

Covid-19 testing

An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2 viruses responsible for Covid-19. . . . → Read More: Simpler Method Devised to Validate Covid-19 Tests